112 related articles for article (PubMed ID: 24592886)
1. MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy.
Ayad MW; El Naggar AA; El Naggar M
Eur J Haematol; 2014 Jul; 93(1):63-9. PubMed ID: 24592886
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
Nasr AS; Sami RM; Ibrahim NY
J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
[TBL] [Abstract][Full Text] [Related]
4. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Kantar M; Kosova B; Cetingul N; Gumus S; Toroslu E; Zafer N; Topcuoglu N; Aksoylar S; Cinar M; Tetik A; Eroglu Z
Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
[TBL] [Abstract][Full Text] [Related]
6. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
Eissa DS; Ahmed TM
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
[TBL] [Abstract][Full Text] [Related]
7. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
Ongaro A; De Mattei M; Della Porta MG; Rigolin G; Ambrosio C; Di Raimondo F; Pellati A; Masieri FF; Caruso A; Catozzi L; Gemmati D
Haematologica; 2009 Oct; 94(10):1391-8. PubMed ID: 19648163
[TBL] [Abstract][Full Text] [Related]
10. The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.
Chiusolo P; Giammarco S; Bellesi S; Metafuni E; Piccirillo N; De Ritis D; Marietti S; Federica S; Laurenti L; Fianchi L; Hohaus S; Giuseppe L; Sica S
Cancer Chemother Pharmacol; 2012 Mar; 69(3):691-6. PubMed ID: 21984221
[TBL] [Abstract][Full Text] [Related]
11. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH;
Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
Giletti A; Vital M; Lorenzo M; Cardozo P; Borelli G; Gabus R; Martínez L; Díaz L; Assar R; Rodriguez MN; Esperón P
Eur J Pharm Sci; 2017 Nov; 109():480-485. PubMed ID: 28887233
[TBL] [Abstract][Full Text] [Related]
13. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
[TBL] [Abstract][Full Text] [Related]
14. 667C>T and 1298A>C polymorphisms of MTHFR do not predict response to methotrexate in patients with gestational trophoblastic neoplasia.
Lasecka L; Dixon PH; Molokhia M; Sharma N; Schleh A; Wang CM; Steel JH; Seckl MJ; Savage PM; Fisher RA
Gynecol Oncol; 2011 Dec; 123(3):605-9. PubMed ID: 21920590
[TBL] [Abstract][Full Text] [Related]
15. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
16. Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate.
D'Angelo V; Ramaglia M; Iannotta A; Francese M; Pota E; Affinita MC; Pecoraro G; Indolfi C; Di Martino M; Di Pinto D; Buffardi S; Poggi V; Indolfi P; Casale F
Leuk Lymphoma; 2013 Dec; 54(12):2639-44. PubMed ID: 23488607
[TBL] [Abstract][Full Text] [Related]
17. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
19. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]